Muthukumar Karuppasamy

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Induced Pluripotent Stem Cells

Emergency Department

Skeletal Muscle

Top Venues

Disease models & mechanisms

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Reviews in endocrine & metabolic disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Muthukumar Karuppasamy, Katherine G English, Clarissa A Henry, M Chiara Manzini, John M Parant, Melissa A Wright, Avnika A Ruparelia, Peter David Currie, Vandana A Gupta, James E Dowling, Lisa Maves, Matthew S Alexander
Standardization of zebrafish drug testing parameters for muscle diseases. Disease models & mechanisms 17 (1) (2024)
Muthukumar Karuppasamy, Katherine G English, Clarissa A Henry, M Chiara Manzini, John M Parant, Melissa A Wright, Avnika A Ruparelia, Peter David Currie, Vandana A Gupta, James E Dowling, Lisa Maves, Matthew S Alexander
Standardization of zebrafish drug testing parameters for muscle diseases. Disease models & mechanisms 17 (1) (2024)
Muthukumar Karuppasamy, Katherine G English, Clarissa A Henry, M Chiara Manzini, John M Parant, Melissa A Wright, Avnika A Ruparelia, Peter David Currie, Vandana A Gupta, James E Dowling, Lisa Maves, Matthew S Alexander
Standardization of zebrafish drug testing parameters for muscle diseases. Disease models & mechanisms 17 (1) (2024)
Muthukumar Karuppasamy, Katherine G English, Clarissa A Henry, M Chiara Manzini, John M Parant, Melissa A Wright, Avnika A Ruparelia, Peter David Currie, Vandana A Gupta, James E Dowling, Lisa Maves, Matthew S Alexander
Standardization of zebrafish drug testing parameters for muscle diseases. Disease models & mechanisms 17 (1) (2024)
Muthukumar Karuppasamy, Katherine G English, Clarissa A Henry, M Chiara Manzini, John M Parant, Melissa A Wright, Avnika A Ruparelia, Peter David Currie, Vandana A Gupta, James E Dowling, Lisa Maves, Matthew S Alexander
Standardization of zebrafish drug testing parameters for muscle diseases. Disease models & mechanisms 17 (1) (2024)
Muthukumar Karuppasamy, Katherine G English, Clarissa A Henry, M Chiara Manzini, John M Parant, Melissa A Wright, Avnika A Ruparelia, Peter David Currie, Vandana A Gupta, James E Dowling, Lisa Maves, Matthew S Alexander
Standardization of zebrafish drug testing parameters for muscle diseases. Disease models & mechanisms 17 (1) (2024)
Muthukumar Karuppasamy, Katherine G English, Clarissa A Henry, M Chiara Manzini, John M Parant, Melissa A Wright, Avnika A Ruparelia, Peter David Currie, Vandana A Gupta, James E Dowling, Lisa Maves, Matthew S Alexander
Standardization of zebrafish drug testing parameters for muscle diseases. Disease models & mechanisms 17 (1) (2024)
Muthukumar Karuppasamy, Katherine G English, Clarissa A Henry, M Chiara Manzini, John M Parant, Melissa A Wright, Avnika A Ruparelia, Peter David Currie, Vandana A Gupta, James E Dowling, Lisa Maves, Matthew S Alexander
Standardization of zebrafish drug testing parameters for muscle diseases. Disease models & mechanisms 17 (1) (2024)
Adrienne Samani, Muthukumar Karuppasamy, Katherine G English, Colin A Siler, Yimin Wang, Jeffrey J Widrick, Matthew S Alexander
DOCK3 regulates normal skeletal muscle regeneration and glucose metabolism. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 37 (10) (2023)
Manoj Kumar Mahapatra, Muthukumar Karuppasamy, Biswa Mohan Sahoo
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. Reviews in endocrine & metabolic disorders 23 (3) (2022)
Shen H Tan, Muthukumar Karuppasamy, Ping Lan, Yao-Chun Zhang, Jiayi Hu, Xingchen Lai, Belinda Siok-Cheng Lim, Weiliang Liu, Jing Chen, Eng Hui Chew, Martin G Banwell
Ribisins and Certain Analogues Exert Neuroprotective Effects through Activation of the Keap1-Nrf2-ARE Pathway. ChemMedChem 17 (18) (2022)